Security key
15117B202
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)
CUSIP: 15117B202
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.001
- Shares outstanding
- 80,000,000
- Total 13F shares
- 48,218,738
- Share change
- -1,376,864
- Total reported value
- $1,300,004,065
- Put/Call ratio
- 52%
- Price per share
- $26.96
- Number of holders
- 146
- Value change
- -$45,672,202
- Number of buys
- 63
- Number of sells
- 74
Report period
Q2 2022
Institutions
146
Top holders
10
CLDX full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Celldex Therapeutics, Inc. SEC filings
Celldex Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117B202
Recent filing periods:
Top shareholders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
8.8%
|
7,010,253
|
$238,769,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.4%
|
3,529,840
|
$120,227,000 | — | 31 Mar 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.9%
|
3,084,215
|
$105,048,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.8%
|
3,046,822
|
$103,773,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
2,682,728
|
$91,374,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
2,433,595
|
$82,889,000 | — | 31 Mar 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.6%
|
2,075,000
|
$70,675,000 | — | 31 Mar 2022 | |
| Redmile Group, LLC |
13F
|
Company |
2.6%
|
2,046,269
|
$69,696,000 | — | 31 Mar 2022 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
2.3%
|
1,846,647
|
$62,897,000 | — | 31 Mar 2022 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,445,700
|
$49,241,000 | — | 31 Mar 2022 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1.6%
|
1,250,000
|
$42,575,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
1,135,113
|
$38,662,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
1,054,325
|
$35,910,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
1,019,024
|
$34,708,000 | — | 31 Mar 2022 | |
| Venrock Adviser, LLC |
13F
|
Company |
1.1%
|
865,116
|
$29,466,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
855,513
|
$29,138,000 | — | 31 Mar 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
800,000
|
$27,248,000 | — | 31 Mar 2022 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.95%
|
761,398
|
$25,933,000 | — | 31 Mar 2022 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.94%
|
753,034
|
$25,648,000 | — | 31 Mar 2022 | |
| Eversept Partners, LP |
13F
|
Company |
0.8%
|
636,453
|
$21,677,589 | — | 31 Mar 2022 | |
| Vivo Capital, LLC |
13F
|
Company |
0.79%
|
628,356
|
$21,402,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.74%
|
592,358
|
$20,176,000 | — | 31 Mar 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.72%
|
579,192
|
$19,727,000 | — | 31 Mar 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.67%
|
537,958
|
$18,323,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
439,534
|
$14,970,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.51%
|
406,100
|
$13,832,000 | — | 31 Mar 2022 | |
| Tri Locum Partners LP |
13F
|
Company |
0.48%
|
383,319
|
$13,056,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.42%
|
336,808
|
$11,472,000 | — | 31 Mar 2022 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.4%
|
322,898
|
$10,998,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.38%
|
303,419
|
$10,335,000 | — | 31 Mar 2022 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.38%
|
300,000
|
$10,218,000 | — | 31 Mar 2022 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.37%
|
292,292
|
$9,955,000 | — | 31 Mar 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.35%
|
277,481
|
$9,451,000 | — | 31 Mar 2022 | |
| Commodore Capital LP |
13F
|
Company |
0.3%
|
241,199
|
$8,215,000 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.29%
|
228,948
|
$7,798,000 | — | 31 Mar 2022 | |
| Sessa Capital IM, L.P. |
13F
|
Company |
0.26%
|
212,000
|
$7,221,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.26%
|
206,700
|
$7,041,000 | — | 31 Mar 2022 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.26%
|
204,535
|
$6,966,000 | — | 31 Mar 2022 | |
| Opaleye Management Inc. |
13F
|
Company |
0.24%
|
195,500
|
$6,659,000 | — | 31 Mar 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.23%
|
183,017
|
$6,234,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.23%
|
180,890
|
$6,161,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
160,779
|
$5,476,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.2%
|
156,252
|
$5,322,000 | — | 31 Mar 2022 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
155,804
|
$5,307,000 | — | 31 Mar 2022 | |
| AXA S.A. |
13F
|
Company |
0.19%
|
154,923
|
$5,276,677 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.19%
|
154,000
|
$5,245,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
153,703
|
$5,236,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
133,926
|
$4,550,000 | — | 31 Mar 2022 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.17%
|
132,571
|
$4,515,000 | — | 31 Mar 2022 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.16%
|
125,000
|
$4,258,000 | — | 31 Mar 2022 |
Institutional Holders of Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) as of Q2 2022
As of 30 Jun 2022,
Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX) was held by
146 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,218,738 shares.
The largest 10 holders included
FMR LLC, STATE STREET CORP, BlackRock Inc., RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., Redmile Group, LLC, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
147
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
157
Q2 2022 holders
146
Holder diff
-11
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.